LCD L39684: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — Noridian
Policy LCD-L39684 · Endocrinology
New LCD affects billing for thyroid nodule testing.
Code intelligence
D75.81 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code D75.81.
Elevated code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Elevated
0
Critical
0%
3
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36400: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) — WPS
Policy LCD-L36400 · Hematology
New LCD on genetic testing may impact billing practices.
Proposed LCD DL40242: MolDX: Genetic Testing for Hereditary Thrombophilia — Noridian
Policy LCD-DL40242 · Hematology
New LCD for hereditary thrombophilia testing impacts billing.
Audit documentation
Building an audit file that includes D75.81?
The Tripwire Audit Pack exports 12 months of Endocrinology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Endocrinology audit pack — $349One-time purchase · not a subscription